Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hao Yi Sheng Pharmaceutical Will Build First cGMP Plant In Sichuan

This article was originally published in PharmAsia News

Executive Summary

Hao Yi Sheng (Good Doctor) Pharmaceutical recently held a ground-breaking ceremony in the Anxian Industrial Park in Mianyang city, in Sichuan province. The company will invest RMB 380 million to build its first certified cGMP-standard production base in the southwest of China. China is currently one of the main manufacturers and exporters of active pharmaceutical ingredients in the world, with a 20 percent share of the global market. The goal of building this cGMP plant is to have the capacity to produce high value-added APIs, and to supply the European and U.S. markets. India currently produces more than 260 kinds of cGMP-certified APIs, while China makes less than 50. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071097

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel